Transactions

  • October 30, 2017 - Roberta Roller Rabbit has been sold to an investor group

    Avalon Net Worth has identified an investor group for the acquistion of Roberta Roller Rabbit... 

    Read More
  • March 31, 2017 - Atlantic Street Capital portfolio's company, Alex Apparel Group, Inc., have acquired Sally Lou Fashions

    Avalon Net Worth has identified a strategic target company for Atlantic Street Capital and its portfolio company, Alex Apparel Group, to aquire... 

    Read More
  • March 02, 2017 - ANW has advised on the sale of Jaclyn, Inc. (OTCMKTS:JCLY), to an affiliate of Golden Touch Imports, Inc.

    Jaclyn, Inc. (OTCMKTS:JCLY), a $175 million (revenues) multi-line fashion and accessory firm, has been sold to an affiliate of Golden Touch Imports, Inc. ... 

    Read More
  • February 27, 2017 - Molli Partners LLC has sold its four shoe brands to Teshoeque LLC

    Molli Partners LLC has completed a sale of it's major brands to Teshoeque LLC... 

    Read More
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6

Noteworthy

  • October 17, 2017 - Global Private Wealth Dallas Forum on Macroeconomics

    At the 2017 GPW Dallas Forum our Co-CEO, Lynda Davey, spoke alongside other prominent industry executives regarding the current

    Read More
  • July 25, 2017 - Retail Summer School at Columbia Business School

    Richard Jaffe, a Managing Director at Avalon, along with Shoptalk, will host the 9th Annual Retail Summer School at

    Read More
  • May 10, 2017 - Retail’s Private Equity Legacy: Big Debt, Big Problems

    In an article published by WWD magazine our Co-CEO, Jack Hendler, shares his insight on Private Equity in the

    Read More
  • April 04, 2017 - Why Millennials and Mid-Market Firms Are a Fashion Match

    Apparel magazine published an article where our Co-CEO, Jack Hendler, discusses Milennials and Retail...    Read More...

    Read More
  • 1
  • 2
  • 3
  • 4
  • 5

Avalon Group Ltd. is pleased to announce another two successful closings

Cytomedix, Inc. (NYSE Amex:GTF) Registered Direct Offering

ROCKVILLE, Md., Aug. 27, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF) ("the Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced it entered into securities purchase agreements with investors to raise gross proceeds of approximately $420,000, before placement agent's fees and other offering expenses, in a registered direct offering. This represents the second and final tranche to the financing previously announced on August 12, 2009, which raised an initial approximate $1,050,000. The offering is expected to close on or about August 31, 2009. Proceeds will be used for general corporate purposes. Avalon Securities Ltd. acted as exclusive placement agent, on a "best efforts" basis, for this transaction.

Cytomedix develops, sells and licenses regenerative biological therapies including the AutoloGel (tm) System, a device for the production of Platelet Rich Plasma gel derived from the patient's own blood. The AutoloGel (tm) System is cleared by the U.S. Food and Drug Administration for use on a variety of exuding wounds. The Company is pursuing a multifaceted strategy to penetrate the chronic wound market with its AutoloGel (tm) System and is moving forward with the development of other product candidates in its pipeline. Most notably is its CT-112 product, an anti-inflammatory peptide that has shown promise in preclinical testing. 

This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities in this offering, nor will there be any sale of these securities in any jurisdiction in which such offer solicitation or sale are unlawful prior to registration or qualification under securities laws of any such jurisdiction.

Cubic Energy Inc. (NYSE Amex:QBC)Unregistered Sale of Equity Securities

On August 18 and August 26, 2009, Cubic Energy, Inc. (the "Company") entered into Subscription and Registration Rights Agreements (the "Subscription Agreements") with certain investors (the "Investors"). Pursuant to the Subscription Agreements, the Company issued 804,000 shares of common stock on August 18, 2009, and 1,300,001 shares of common stock on August 26, 2009, for an aggregate of 2,104,001 shares. Avalon Securities Ltd. acted as exclusive placement agent, on a "best efforts" basis, for this transaction.

Pursuant to the Subscription Agreements, the Investors paid aggregate consideration of approximately $1,788,400 to the Company for 2,104,001 shares of the Company's common stock and warrants exercisable into 1,052,000 shares of common stock. The warrants are exercisable through July 31, 2014, at $0.85 per share. The shares and warrants were issued by the Company in reliance upon an exemption from registration set forth in Regulation D and/or Section 4(2) of the Securities Act of 1933, as amended. On September 1, 2009, the Company issued a press release with respect to this item.

About Avalon Group, Ltd.

Avalon Group, Ltd. provides clients access to the quality and technical expertise of a major investment bank while maintaining the confidential personal service and efficiency of a boutique firm. Our services include arranging private investments, registered direct offerings, and PIPEs, and providing fairness opinions, mergers and acquisitions, restructuring, and strategic advisory services. Since 1992, Avalon has worked with high caliber, committed corporate leaders to expand their business, re-capitalize or re-organize firms, sell or purchase divisions, and arrange liquidity events. Our clients have ranged from mid-market private companies to Fortune 500 companies to international entities and early stage firms. Avalon Group and Avalon Securities, its affiliated FINRA, SIPC and SEC registered broker-dealer, are located in mid-town Manhattan.

Avalon’s Capital Markets team offers capital raising and advisory services to public companies. As part of this process, we analyze our client’s operations to create solutions that are tailored to each client’s needs. We provide our clients with strategic introductions and access to institutional money managers, family offices, and high net worth individuals.